Global Intravenous Immunoglobulins Market 2017-2021
- SKU ID : TNV-IRTNTR13212 10672705
- |
- Publishing Date: 31-May-2017
- |
- Region: Global
- |
- No. of pages: 70
About Intravenous Immunoglobulins
Immunoglobulins are glycoprotein molecules produced by plasma cells. They are a critical part of a body's immune response and they do so by specifically recognizing and binding to microbes and destroying them. These immunoglobulins are produced by a body naturally, but due to some genetic or infectious diseases, the natural production of immunoglobulin is inhibited, resulting in an immune-compromised condition.
Technavio’s analysts forecast the global intravenous immunoglobulins market to grow at a CAGR of 7.62% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global intravenous immunoglobulins market for 2017-2021. To calculate the market size, the report considers sales from both generic and branded drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Intravenous Immunoglobulins Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• CSL Behring
• Grifols
• Octapharma
• Shire
Other prominent vendors
• ADMA Biologics
• Bayer
• Bharat Serum and Vaccines
• Biotest AG
• China Biologic Products
• Hualan Biological Engineering
• Kedrion Biopharma
• LFB Group
• Sanquin
Market driver
• Growing number of fractionating units
• For a full, detailed list, view our report
Market challenge
• Complex and cost-intensive manufacturing
• For a full, detailed list, view our report
Market trend
• Monetary support to plasma donors
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Immunoglobulins are glycoprotein molecules produced by plasma cells. They are a critical part of a body's immune response and they do so by specifically recognizing and binding to microbes and destroying them. These immunoglobulins are produced by a body naturally, but due to some genetic or infectious diseases, the natural production of immunoglobulin is inhibited, resulting in an immune-compromised condition.
Technavio’s analysts forecast the global intravenous immunoglobulins market to grow at a CAGR of 7.62% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global intravenous immunoglobulins market for 2017-2021. To calculate the market size, the report considers sales from both generic and branded drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Intravenous Immunoglobulins Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• CSL Behring
• Grifols
• Octapharma
• Shire
Other prominent vendors
• ADMA Biologics
• Bayer
• Bharat Serum and Vaccines
• Biotest AG
• China Biologic Products
• Hualan Biological Engineering
• Kedrion Biopharma
• LFB Group
• Sanquin
Market driver
• Growing number of fractionating units
• For a full, detailed list, view our report
Market challenge
• Complex and cost-intensive manufacturing
• For a full, detailed list, view our report
Market trend
• Monetary support to plasma donors
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
